Management of Neurologic Diseases

  • Authors: David M. Simpson, MD; Jessica Robinson-Papp, MD (More Info)
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 4/1/16 (What's New)

Summary

  • Corticosteroids are often used to reduce mass effect and edema in brain lesions
  • They can also significantly reduce the size of PCNSL lesions and alter the pathologic appearance of PCNSL, with potential to confuse interpretation of treatment effects[Ferreri 2011; Morgello 2006]
  • Corticosteroids should be used judiciously and primarily in cases where edema and mass effect are of significant concern

Action required

Keywords: Cancer, IRIS, Neurologic Complications

©2020 Clinical Care Options, LLC. All Rights Reserved.

The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.